Vol 57, No 5 (2006)
Original paper
Published online: 2006-11-06
The effect of weight loss on serum concentrations of nitric oxide, TNF-alfa and soluble TNF-alfa receptors
Endokrynol Pol 2006;57(5):487-493.
Abstract
Introduction: The aims of the present study were to evaluate
the effect of weight-loss treatment on serum concentrations
of NO and TNF-α and to examine whether there is an
association between TNF-system activity and serum concentrations
of NO after weight loss.
Material and methods: The study group involved 43 obese women (aged 41.8 ± 11.9 years, weight 95.2 ± 15.0 kg, BMI 36.5 ± 4.6 kg/m2). The women were subjected to threemonth complex weight-loss treatment. Patients were advised to keep to a 1000-1200 kcal diet and to exercise regularly. Pharmacological treatment was not administered. Serum concentrations of nitric oxide metabolites, TNF-α and its soluble receptors (sTNFR1, sTNFR2) were measured by ELISA kits; insulin was measured by RIA and glucose, cholesterol, HDL cholesterol and triglicerydes by an enzymatic procedure before and after weight loss. Body composition was determined by impedance analysis using Bodystat.
Results: The mean weight loss during treatment was 8.3 ± 4.3 kg. The serum concentrations of TNF-α decreased significantly (p < 0.000) and both receptors sTNFR1 and sTNFR2 increased significantly (p < 0.000) after weight loss. No significant changes in serum concentrations of NO were observed after weight loss. A multiple regression analysis was performed using ΔTNF-α, ΔsTNFR1, ΔTNFR2 and ΔNO as dependent variables. A significant correlation was observed between DNO and initial plasma concentrations of TNF-α, sTNFR1 and sTNFR2.
Conclusions: This study demonstrates a decrease in serum TNF-α concentration as well as an increase in plasma concentration of both TNF receptors but does not show any change in serum concentrations of NO after weight-loss treatment in obese women. It seems that changes in TNF-system activity may be a counter-regulating mechanism, which inhibits further body mass loss. We did not observe any association between changes in TNF-system activity and serum concentrations of NO after weight loss.
Material and methods: The study group involved 43 obese women (aged 41.8 ± 11.9 years, weight 95.2 ± 15.0 kg, BMI 36.5 ± 4.6 kg/m2). The women were subjected to threemonth complex weight-loss treatment. Patients were advised to keep to a 1000-1200 kcal diet and to exercise regularly. Pharmacological treatment was not administered. Serum concentrations of nitric oxide metabolites, TNF-α and its soluble receptors (sTNFR1, sTNFR2) were measured by ELISA kits; insulin was measured by RIA and glucose, cholesterol, HDL cholesterol and triglicerydes by an enzymatic procedure before and after weight loss. Body composition was determined by impedance analysis using Bodystat.
Results: The mean weight loss during treatment was 8.3 ± 4.3 kg. The serum concentrations of TNF-α decreased significantly (p < 0.000) and both receptors sTNFR1 and sTNFR2 increased significantly (p < 0.000) after weight loss. No significant changes in serum concentrations of NO were observed after weight loss. A multiple regression analysis was performed using ΔTNF-α, ΔsTNFR1, ΔTNFR2 and ΔNO as dependent variables. A significant correlation was observed between DNO and initial plasma concentrations of TNF-α, sTNFR1 and sTNFR2.
Conclusions: This study demonstrates a decrease in serum TNF-α concentration as well as an increase in plasma concentration of both TNF receptors but does not show any change in serum concentrations of NO after weight-loss treatment in obese women. It seems that changes in TNF-system activity may be a counter-regulating mechanism, which inhibits further body mass loss. We did not observe any association between changes in TNF-system activity and serum concentrations of NO after weight loss.
Keywords: nitric oxideTNF-αsoluble TNF receptorsweight
